![Page 1: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/1.jpg)
![Page 2: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/2.jpg)
![Page 3: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/3.jpg)
![Page 4: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/4.jpg)
![Page 5: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/5.jpg)
![Page 6: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/6.jpg)
Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44; INTERMEDIATE RISK: 31, 33, 35, 51, 52; HIGH RISK: 16, 18, 45, 56
![Page 7: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/7.jpg)
HPV-Induced Oncogenesis: Viral Events HPV-Induced Oncogenesis: Viral Events Integration at the E2 site leads to its deactivation Integration at the E2 site leads to its deactivation
and release of E6 and E7 gene inhibitionand release of E6 and E7 gene inhibition
![Page 8: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/8.jpg)
HPV-Induced Oncogenesis: Cellular Events E6 binds to p53 and induces its degradation. E7 binds the Rb gene
product, causing the transcription factor E2F-1 to become unbound and free to induce cell cycle activation/growth.
![Page 9: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/9.jpg)
This algorithm generally depicts standard management options for abnormal Pap smears. Options include management of the first ASCUS smear and
management of low-grade lesions (LGSIL). Atypical glandular cells of undetermined significance (AGCUS) should lead to consideration of
colposcopy, endocervical curettage (ECC), and possibly cone biopsy (Bx).
![Page 10: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/10.jpg)
![Page 11: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/11.jpg)
![Page 12: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/12.jpg)
![Page 13: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/13.jpg)
![Page 14: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/14.jpg)
![Page 15: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/15.jpg)
![Page 16: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/16.jpg)
![Page 17: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/17.jpg)
![Page 18: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/18.jpg)
![Page 19: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/19.jpg)
![Page 20: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/20.jpg)
![Page 21: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/21.jpg)
![Page 22: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/22.jpg)
![Page 23: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/23.jpg)
![Page 24: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/24.jpg)
![Page 25: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/25.jpg)
![Page 26: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/26.jpg)
![Page 27: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/27.jpg)
![Page 28: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/28.jpg)
![Page 29: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/29.jpg)
![Page 30: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/30.jpg)
![Page 31: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/31.jpg)
![Page 32: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/32.jpg)
![Page 33: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/33.jpg)
![Page 34: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/34.jpg)
![Page 35: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/35.jpg)
![Page 36: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/36.jpg)
![Page 37: Genital tract HPV types: LOW RISK: 6, 11, 40, 42, 43, 44;](https://reader036.vdocument.in/reader036/viewer/2022062516/56812b3d550346895d8f4fef/html5/thumbnails/37.jpg)